OBJECTIVES: The impact of permanent pacemaker (PPM) leads on functional outcome of tricuspid valve (TV) repair has not been clearly demonstrated. Therefore, controversy exists as to whether transvalvular PPM leads should be explanted and replaced by epicardial leads at the time of valve repair. This study evaluates the influence of PPM leads on functional outcome, TV-related reoperations and survival in patients undergoing TV repair for functional tricuspid regurgitation (TR).
INTRODUCTION
Tricuspid regurgitation (TR) in adults is most commonly functional, defined as regurgitation with morphological normal leaflets and chords, but with an enlargement of the right ventricle and subsequent dilatation and flattening of the tricuspid annulus [1] . A tricuspid valve (TV) repair using annuloplasty rings is the preferred technique over suture repair yielding a lower incidence of residual and recurrent TR, fewer reoperations and an improved survival [2] . The aim of ring annuloplasty is to restore annular geometry, thereby improving leaflet coaptation and preventing further annular dilatation.
There has been a dramatic increase in permanent pacemaker (PPM) and implantable cardioverter-defibrillator implantation over the past decades due to expanding indications, an ageing population and advances in pacemaker technology [3] . Several studies have reported a prevalence of TR ranging from 25-29% in patients with transvalvular pacemaker electrodes. Moreover, a progression of a pre-existing TR by 1 or 2 grades has been observed in up to 25% of patients after device implantation [4] [5] [6] [7] . Potential mechanisms include leaflet laceration or perforation, direct interference with valve closure, scar or thrombus formation impairing leaflet mobility and an asynchronous activation of the right ventricle [3, 8] . Advanced age and the placement of more than one lead across the TV increase the risk for recurrent TR after device implantation [6, 9] .
A substantial proportion of patients undergoing TV repair presents with a pre-existing pacemaker, mostly due to slow conduction atrial fibrillation. The incidence of new PPM implantation following TV surgery is high, varying between 6 and 28% with a new-onset atrioventricular (AV) block being the main indication [10, 11] . However, only a limited number of studies have focussed on the influence of PPM leads on long-term valve function after TV repair. The purpose of this study was to evaluate the impact of transvalvular pacemaker leads on TR recurrence, TV-related reoperations and survival in patients undergoing ring annuloplasty for functional TR.
MATERIALS AND METHODS

Patients
From July 2007 to February 2013, 415 consecutive patients (47% women) underwent TV repair for functional TR with an annuloplasty ring at our institution. Indications for TV repair were symptomatic severe TR as well as mild or moderate TR concomitant with annular dilatation >40 mm in patients undergoing left-sided valve surgery. Patients with endocarditis or organic disease of the TV are not included in the study. Of the remaining patients, 112 (27%) had a transvalvular PPM lead implanted either preoperatively (40 patients, 9.7%) or postoperatively (72 patients, 17.3%). Outcomes of these patients (PACE group) were compared with 303 patients (73%) without a PPM (NO PACE group). This investigation was approved by the Ethics Committee of the Faculty of Medicine of the Technische Universität München (no. 180/14), and patient consent was waived.
Follow-up
The follow-up was closed on October 2013 and is 94% complete. The mean follow-up was 24.4 ± 20.1 months without significant difference between the two groups (P = 0.514), yielding a cumulative total of 845 patient-years. A retrospective review of prospectively collected data was performed using our institutional database. The clinical course and echocardiographic data were obtained from medical records, patient's visits, telephone interviews and communications with the referring physicians.
Echocardiography
Patients were examined by transthoracic echocardiography before and after surgery and during the regular follow-up visits. The reported preoperative TR grade and annulus diameters were measured by transoesophageal echocardiography that was routinely performed in all patients intraoperatively. The severity of regurgitation was classified as grades 0, I (mild), II (moderate) and III (severe) and was assessed in a semi-quantitative manner by means of colour Doppler flow mapping. For detection of regurgitation, a colour flow Doppler was used with a Nyquist limit (aliasing velocity of 50-60 cm/s) and a colour gain that just eliminated random colour speckle from non-moving areas. The vena contracta was measured in the apical four-chamber view focusing on the TV as the narrowest portion of the jet that occurred at the orifice.
Operative technique
All operations were performed on cardiopulmonary bypass under systemic hypothermia. In 197 patients (47.5%), a Contour 3D ring (Medtronic, Minneapolis, MN, USA) was used and in 218 patients (52.5%) an MC3 ring (Edwards Lifescience, Irvine, CA, USA) was used for TV annuloplasty. Interrupted intra-annular sutures were used for ring fixation. All patients were discharged on a regimen of phenprocoumon for the first 3 months postoperatively. . Risk factors for 30-day mortality were analysed using univariate and multivariate logistic regression. Results were reported as odds ratio (OR) with 95% confidence interval (CI). Risk factors for long-term mortality and recurrent TR were evaluated using univariate and multivariate Cox proportional hazard models. Results were reported as hazard ratio (HR) with 95% CI. For regression models, a stepwise forward (Likelihood ratio) selection was used with a probability (P) value of <0.05 as inclusion criterion and >0.10 as exclusion criterion. Survival, freedom from reoperation and recurrent TR were analysed with Kaplan-Meier methods and the log-rank test. A P-value of <0.05 was considered significant. Operative mortality was defined as death occurring within 30 days of surgery or during the index hospitalization. Postoperative complications were analysed according to the 'Guidelines for Reporting Morbidity and Mortality after Cardiac Valvular Operations' approved by the Society of Thoracic Surgeons [12] .
Statistical analysis
RESULTS
Patients
Demographic and clinical data are presented in Table 1 . The mean age of the study population was 70.2 ± 9.8 (26-87) years. Upon admission, 76.6% of the patients were in New York Heart Association (NYHA) functional class III or IV and the mean logistic European System for Cardiac Operative Risk Evaluation (EuroSCORE) was 12.4 ± 13.6% (median 8%, IQR 5-15%). Pulmonary arterial hypertension was present in 67% of the patients and a cardiac operation had been previously performed in 72 patients (17.3%). Of note, 36.6% of the patients presented with a moderate (GFR: 30-59 ml/ minute) and 4.8% with a severe reduction in glomerular filtration rate (GFR: <30 ml/min). Patients in both groups had similar preoperative baseline characteristics. More patients in the PACE group exhibited atrial fibrillation (76.8 vs 65.7%, P = 0.034) and were in NYHA class III or IV (82.1 vs 74.6%, P = 0.038) than patients without a PPM. There was no statistical difference in age, comorbidities, leftventricular function and type of annuloplasty ring used.
Operative data
Grade II TR was present in 39.5% and grade III TR in 56.9% of patients. The mean TV annulus diameter was 44.8 ± 5.4 mm (24.0 ± 3.7 mm/m 2 body surface area) and the mean size of the implanted annuloplasty ring was 31.9 ± 1.8 mm. The majority of the patients (95.4%) underwent a combined procedure (mitral valve: 76.9%, aortic valve: 24.8%, coronary artery bypass grafting: 24.6%, aortic surgery: 5.8% or MAZE: 9.6%). In 94.7% of patients, a median sternotomy was chosen as operative access. The mean cardiopulmonary bypass time was 135.2 ± 54.2 (P = 0.497) and the mean aortic cross-clamp time was 81.9 ± 36.3 min (P = 0.123) without significant differences between the two groups. Sixty-eight patients (16.4%) were operated on an urgent or emergent basis. Operative data are summarized in Table 2 .
Postoperative PPM implantation was required in 72 patients (17.3%). Indications were atrial fibrillation with slow ventricular response in 31, new onset third-degree AV block in 34 and sinus node dysfunction in 7 patients. In the majority of cases (62 patients), the PPM was implanted within the first postoperative month (median 7 days). Among the patients who required a PPM for advanced AV block (8.2% of all patients), 6 exhibited a right bundle branch block, 3 a left bundle branch block, 5 a AV block grade I and 1 an AV block grade II on preoperative electrocardiogram.
Early mortality
All-cause 30-day mortality was 7.1% in the PACE group and 7.6% in the NO PACE group (P = 0.878), respectively (overall 7.5%).
Operative mortality was 8.2% without significant difference between groups (P = 0.635). Univariate analysis revealed age (OR: 
Functional outcome
Echocardiography at hospital discharge documented TR grade 0 in 161 (42.5%), grade I in 191 (50.4%) and grade II in 27 patients (7.1%). In 2 patients, echocardiographic data were missing. The rate of residual ≥II TR was not significant different between the two types of annuloplasty rings used (P = 0.679). The mean TR grade was reduced from 2.47 ± 0.52 preoperatively to 0.70 ± 0.54 (median: 1.0, IQR: 0-1) at hospital discharge (P < 0.001). Freedom 
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from ≥II TR at 5 years ( Fig. 1 ) was 81.3 ± 6.3% in the PACE group and 89.1 ± 3.6% in the NO PACE group (P = 0.113), respectively (overall 86.7 ± 3.2%). Risk factors for TR recurrence are presented in Table 3 Twenty-five patients (6.0%) underwent a reoperation using cardiopulmonary bypass, including 8 (7.1%) in the PACE group and 17 patients (5.6%) in the NO PACE group, respectively. Freedom from cardiac reoperations at 5 years was 90.4 ± 2.6% without significant difference between the groups (P = 0.615). The causes of reoperation were recurrent severe mitral regurgitation in 13 (3.1%), redo coronary artery bypass grafting in 2 (0.5%), recurrent TR in 6 (1.4%) and prosthetic valve endocarditis in 4 (1.0%) patients. Prosthetic valve endocarditis was not associated with pacemaker infection in any patient. In 4 patients with recurrent TR, a TV replacement with a biological prosthesis was performed, in 2 patients valve competency was achieved by commissural sutures. No case of TV ring dehiscence occurred. Freedom from TV-related reoperation at 5 years was 97.0 ± 1.7% in the PACE group and 98.5 ± 0.9% in the NO PACE group (P = 0.206), respectively (overall 98.1 ± 0.8%). Eleven patients with a PPM underwent a reintervention for a device-related complication. Ten patients were reoperated for lead dislodgement and 1 patient for a local infection at the implantation side. The pacemaker was completely removed and implanted on the contralateral side after a 3-week course of antibiotic therapy.
Long-term survival
Among perioperative survivors, a total of 34 patients died during the follow-up. Overall mortality within the observational period was 16.4%. Survival probability at 5 years ( Fig. 2) was 74.5 ± 6.6% in the PACE group and 78.3 ± 3.2% in the NO PACE group (P = 0.830), respectively (overall 76.9 ± 3.1%). Risk factors for long-term mortality are presented in 
DISCUSSION
Residual or recurrent TR after TV repair occurs in 20-30% of patients leading to reduced exercise capacity and congestive right heart failure [2, 13, 14] . Various predictors of TV repair failure have been previously identified, such as a higher preoperative TR grade, extensive leaflet tethering (>10 mm), ventricular dysfunction, atrial fibrillation and pulmonary arterial hypertension [2, 15] . The aim of the present study was to evaluate the impact of transvalvular pacemaker leads on TR recurrence, TV-related reoperations and survival in a large patient cohort undergoing TV repair for functional TR.
In the present cohort, the preoperative grade of TR was efficiently reduced from 2.47 ± 0.52 to 0.70 ± 0.54 (P < 0.001). Freedom from ≥II TR at 5 years was 86.7 ± 3.2%, which corresponds well to mid-term results after TV repair using three-dimensional annuloplasty rings from recent trials, yielding 85-90% freedom from recurrent moderate-to-severe TR at 3 years [16] . There was no significant difference in functional outcome between the PACE and NO PACE group. Upon uni-and multivariate analyses, the presence of a transvalvular PPM lead was not associated with TR recurrence in our series. The preoperative TR grade and atrial fibrillation were significant predictors of repair failure, which is in accordance with results from other studies [2, 17, 18] .
Contradictory to our findings, Mazine et al. [17] found the presence of a transvalvular PPM lead to be a significant predictor for recurrent ≥II TR (HR: 1.6; P = 0.008) and late mortality (HR: 2.12; P = 0.02). In contrast to our series, the study covered a 30-year period from 1977 and included also patients with organic TV disease and different repair techniques including suture annuloplasty. McCarthy et al. [2] retrospectively analysed 790 patients who underwent TV repair with either suture or ring annuloplasty including 75 patients with a preoperatively implanted PPM. The presence of a transvalvular PPM was identified as risk factor for recurrent TR beyond 6 months. Five years after valve repair, 42% of patients with a PPM had severe TR, almost twice as high as those without a device. The authors concluded that transvalvular PPM leads should be removed upon repair of the TV and replaced with epicardial leads at the time of surgery. However, no information was given regarding TR recurrence in patients with postoperative PPM implantation.
Patients with severe TR often present with an advanced stage of heart failure and thus the operative mortality is high, ranging between 4 and 14% [2, 13, 19, 20] . In our study, overall 30-day mortality was 7.5% without significant difference between the PACE and NO PACE group, which corresponds to results from another recent trial [17] . 76.6% of our patients presented in NYHA class III or IV, 16.4% were operated on an urgent or emergent basis, 67% had pulmonary arterial hypertension and 41.4% a moderate or severe impairment of renal function, all of which have been previously identified as significant predictors of increased mortality [20, 21] .
The long-term survival of patients undergoing TV surgery is poor with a reported 8-year survival of 50%, regardless of the type of repair technique used [2] . Pfannmueller et al. [22] analysed the outcomes of 116 patients with a previously implanted transvalvular PPM who underwent TV repair and reported a 5-year survival of 45%. Unfortunately, this report lacks a control group and no information is given on the functional outcome. In our series, survival probability at 5 years was 76.9 ± 3.1% without significant difference between patients in the PACE and NO PACE group. The presence of a PPM was not identified as risk factor for late mortality upon uni-and multivariate analyses.
Patients with failure of TV repair requiring reoperation exhibit a high operative mortality of 35% and a poor long-term survival [23] . Due to the high operative risk, such patients are therefore usually treated medically and only a minority is referred for redo surgery [2, 20] . Freedom from TV-related reoperation at 5 and 10 years has been reported to be 95 and 83%, respectively [20, 24] . In our series, 6 patients (1.4%) required a TV-related reoperation because of recurrent severe TR. Freedom from TV-related reoperation at 5 years was 98.1 ± 0.8% and there was no significant difference between patients with and without a PPM.
The estimated rate of infection after implantation of a PPM is between 1 and 2%. A local infection at the implantation side may track along the electrode to involve the TV or alternatively, the electrode may become infected during bacteraemia. Early and repeat reinterventions for haematoma or lead dislodgement, pulse generator replacement, advanced age, the lack of antibiotic prophylaxis and the presence of multiple electrodes increase the risk for infectious complications [25] . We removed the complete pacemaker system in one of our patients because of a local infection of the pacemaker pocket, but, without evidence of endocarditis.
LIMITATIONS
Our study is a retrospective study with all the inherent limitations. The mean follow-up is limited to 2 years. Since all patients underwent TV ring annuloplasty for functional regurgitation, our findings may not be translated to patient cohorts who differ in aetiology and repair technique. Tethering of leaflets was not consistently reported in echocardiographic reports and could therefore not be used for analysis.
CONCLUSION
In patients undergoing TV ring annuloplasty for functional TR, the presence of a transvalvular pacemaker lead is not a risk factor for recurrent moderate-to-severe TR, TV-related reoperation and long-term mortality.
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